Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)
China flag China · Delayed Price · Currency is CNY
18.70
-0.05 (-0.27%)
At close: Feb 13, 2026

SHE:002932 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
183.86493.911,0162,5561,190669.11
Short-Term Investments
3,162738.79-70--
Trading Asset Securities
404.9264.12122.591,953700200
Cash & Short-Term Investments
3,7501,2971,1384,5781,890869.11
Cash Growth
572.47%13.93%-75.14%142.22%117.48%134.57%
Accounts Receivable
652.72766.951,2542,736740.42185.03
Other Receivables
17.8180.5270.2817.5211.975.46
Receivables
670.53847.471,3242,754752.39190.49
Inventory
101.3582.3128.77258.44284.59117.73
Other Current Assets
224.06171.08158.8391.0972.9840.77
Total Current Assets
4,7462,3982,7507,6823,0001,218
Property, Plant & Equipment
676.65721.68543.6521.59243.47123.26
Long-Term Investments
254.22257.61156.3683.4960.6246.4
Other Intangible Assets
16.6117.317.721.2416.5916.93
Long-Term Deferred Tax Assets
216.26216.9210.18173.9516.637.6
Long-Term Deferred Charges
2.323.1114.8717.211.451.74
Other Long-Term Assets
188.682,9793,694695.3378.2412.61
Total Assets
6,1016,5937,3879,1953,4171,427
Accounts Payable
144.76278.11681.581,294174.3130.94
Accrued Expenses
52.3887.97154.94364.6883.1829.78
Short-Term Debt
3323.61164.6730141.5
Current Portion of Leases
4.34.37.2918.173.62-
Current Income Taxes Payable
5.776.446.27144.02131.824.58
Current Unearned Revenue
35.2837.9653.17309.5871.1827.74
Other Current Liabilities
52.0178.0792.569.9651.954.87
Total Current Liabilities
297.5495.861,0192,365545.98309.42
Long-Term Leases
3.455.8218.2520.7510.74-
Long-Term Unearned Revenue
20.8720.8714.265.965.960.02
Long-Term Deferred Tax Liabilities
51.6750.4239.5931.074.332.32
Other Long-Term Liabilities
0.221.443.03---
Total Liabilities
373.7574.41,0942,423567.02311.77
Common Stock
232.5232.52232.52156.19104.8869.01
Additional Paid-In Capital
818.1818.1820.18887.89904.5400.24
Retained Earnings
4,7585,0144,9735,4721,812681.94
Treasury Stock
-247.96-237.95--16.02-32.77-49.39
Total Common Equity
5,5615,8266,0266,5002,7891,102
Minority Interest
166.32192.29266.21271.9261.2513.09
Shareholders' Equity
5,7276,0196,2926,7722,8501,115
Total Liabilities & Equity
6,1016,5937,3879,1953,4171,427
Total Debt
10.7513.1149.16203.5944.36141.5
Net Cash (Debt)
3,7401,2841,0894,3751,846727.61
Net Cash Growth
605.79%17.87%-75.10%137.02%153.67%96.38%
Net Cash Per Share
17.245.684.8019.038.723.49
Filing Date Shares Outstanding
219.47220.05232.52232.73232.84214.48
Total Common Shares Outstanding
219.47220.05232.52232.73232.84214.48
Working Capital
4,4491,9021,7315,3172,454908.68
Book Value Per Share
25.3426.4825.9227.9311.985.14
Tangible Book Value
5,5455,8096,0086,4792,7721,085
Tangible Book Value Per Share
25.2626.4025.8427.8411.915.06
Buildings
-440.3116.98116.667851.08
Machinery
-380.8402.91374.05158.18113.44
Construction In Progress
-120.79185.19121.5273.5819.02
Source: S&P Global Market Intelligence. Standard template. Financial Sources.